Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Neurological Sciences
Literature
1.
2.
3.
4.
Hausfater P, Costedoat-Chalumeau N, Amoura Z et al (2005) AL cardiac amyloidosis and arterial thromboembolism. Scand J Rheumatol 34:315–319CrossRef
5.
Roberts WC, Waller BF (1983) Cardiac amyloidosis causing cardiac dysfunction: analysis of 54 necropsy patients. Am J Cardiol 52:137–146CrossRefPubMed
6.
Stables RH, Ormerod OJ (1996) Atrial thrombi occurring during sinus rhythm in cardiac amyloidosis: evidence for atrial electromechanical dissociation. Br J Card Soc 75:426CrossRef
7.
Feng D, Syed IS, Martinez M et al (2009) Intracardiac thrombosis and anticoagulation therapy in cardiac amyloidosis. AHA J Hematol 119:2490–2497
8.
Dispenzieri A, Gertz MA, Buadi F (2012) What do i need to know about immunoglobulin light chain (AL) amyloidosis? Blood Review 26:137–154CrossRef
Metadata
Title
Acute ischemic stroke as initial manifestation of cardiac amyloidosis
Author
Abhishek Dixit
Publication date
11-04-2024
Publisher
Springer International Publishing
Published in
Neurological Sciences
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-024-07442-7